AI assistant
CONMED Corp — Director's Dealing 2016
Oct 4, 2016
31971_dirs_2016-10-04_67aab0e7-a948-4234-819c-80ab747d47cc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2016-09-30
Reporting Person: Lande Jerome J. (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-09-30 | Options To Purchase Common Stock | $41.06 | D | 5396 | Disposed | 2026-06-01 | Common Stock (5396) | Direct |
| 2016-09-30 | Rsus (restricted Stock Units) | $0 | D | 2739 | Disposed | 2026-06-01 | Common Stock (2739) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 7000 | Direct |
Footnotes
F1: At Mr. Lande's request, the Board cancelled his 2016 RSUs and Stock Options. Mr. Lande received no value for the cancellation of these RSUs and Stock Options.
F2: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and otherwise would have vested 100% after a one year period.
F3: Each restricted stock unit ("RSU") represented a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and were subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs otherwise generally vesting 100% after a one year period.